Treatment outcomes after highly-purified human menopausal gonadotropin (hp-hmg) ovarian stimulation and luteal support with a novel progesterone vaginal system (pvs): sara trial analysis
To characterize key parameters associated with the use of HP-hMG and PVS in a bridging study designed to evaluate the safety and efficacy of PVS after implementation of manufacturing enhancements.
Source: Fertility and Sterility - Category: Reproduction Medicine Authors: Vicki L. Schnell, Eric D. Foster, Sarah A. Grover, Patrick W. Heiser Source Type: research